实验方案(Protocols)

Recombinant Human Angiopoietin-2 Protein: Research Guide

Recombinant Human Angiopoietin-2 Protein is a biologically active cytokine used to study Tie2 receptor signaling, vascular remodeling, and angiogenic processes in vitro and in vivo.

Product Name
Recombinant Human Angiopoietin-2 Protein
SKU
rp365025
Target Receptor
Tie2 (TEK) receptor tyrosine kinase
Primary Research Area
Angiogenesis and vascular biology
Protein Origin
Recombinant, human-derived sequence
Recommended Storage
-20°C or -80°C; avoid repeated freeze-thaw cycles

Biological Background and Mechanism of Action

Angiopoietin-2 (Ang-2) is a secreted glycoprotein and a member of the angiopoietin family, which plays a central role in regulating vascular development, remodeling, and stability. Ang-2 acts primarily as a context-dependent ligand for the Tie2 receptor tyrosine kinase, which is predominantly expressed on endothelial cells. Under most physiological conditions, Ang-2 functions as a competitive antagonist of Angiopoietin-1 (Ang-1), disrupting the constitutive Ang-1/Tie2 signaling that maintains vascular quiescence.

The biological outcome of Ang-2/Tie2 engagement is highly context-dependent. In the presence of vascular endothelial growth factor (VEGF), Ang-2 promotes angiogenic sprouting, endothelial cell migration, and neovascularization. In the absence of pro-angiogenic signals, Ang-2 can instead promote vascular regression and endothelial apoptosis. This dual functionality makes Ang-2 a critical regulator at the switch between vascular stability and plasticity.

Ang-2 is upregulated in pathological settings including tumor angiogenesis, inflammatory angiogenesis, and ischemic conditions, making it a relevant target for oncology, ophthalmology, and cardiovascular disease research.

Protein Specifications and Quality Control

Recombinant Human Angiopoietin-2 Protein (SKU: rp365025) is produced using a recombinant expression system to ensure batch-to-batch consistency and biological activity. Researchers should consult the product-specific Certificate of Analysis (CoA) for lot-specific data including purity, endotoxin levels, and bioactivity measurements.

General quality attributes expected for a research-grade recombinant Ang-2 protein include:

  • Purity: Typically >95% as assessed by SDS-PAGE and/or HPLC analysis.
  • Endotoxin Level: Generally <1.0 EU per microgram of protein, as determined by the LAL method, to minimize interference in cell-based assays.
  • Biological Activity: Confirmed via functional assays, such as the ability to inhibit Ang-1-induced Tie2 phosphorylation in endothelial cells or to promote endothelial cell migration in a dose-dependent manner.
  • Formulation: Typically supplied as a lyophilized powder or in a sterile-filtered carrier protein solution; refer to the product datasheet for exact formulation details.

Note: Specific numerical values for purity, endotoxin, and activity are lot-dependent. Always verify current lot data on the CoA provided with each shipment.

Reconstitution and Handling Protocol

Proper reconstitution and handling of Recombinant Human Angiopoietin-2 Protein are critical to preserving biological activity and ensuring reproducible experimental results. Follow the steps below:

  1. Equilibration: Allow the vial to equilibrate to room temperature for 10–15 minutes before opening to minimize condensation-related contamination.
  2. Reconstitution: Reconstitute the lyophilized protein in sterile, ultrapure water or in the buffer specified on the product datasheet (commonly phosphate-buffered saline, pH 7.4, with 0.1–0.2% bovine serum albumin [BSA] as a carrier). Add the reconstitution buffer gently along the side of the vial; do not vortex.
  3. Gentle Mixing: Allow the reconstituted solution to sit for 5 minutes, then gently swirl to ensure complete dissolution. Avoid vigorous agitation, which can denature the protein.
  4. Aliquoting: Prepare single-use working aliquots immediately after reconstitution to avoid repeated freeze-thaw cycles, which degrade protein activity.
  5. Working Concentration: Dilute to the desired working concentration using a suitable cell culture medium or assay buffer. Typical working concentrations in cell-based assays range from 100 ng/mL to 1 µg/mL, but should be determined empirically for each application.

Always refer to the specific product datasheet for the recommended reconstitution volume and buffer composition for SKU rp365025.

Storage Conditions and Stability

Maintaining proper storage conditions is essential for preserving the biological activity of Recombinant Human Angiopoietin-2 Protein over time.

  • Lyophilized (Dry) Form: Store at -20°C upon receipt. When stored under appropriate conditions and protected from moisture, lyophilized protein typically remains stable for up to 12 months. Always verify stability data on the product-specific CoA or datasheet.
  • Reconstituted Form: Once reconstituted, store working aliquots at -80°C for long-term storage. For short-term use (up to 1 week), aliquots may be stored at 2–8°C; however, addition of a carrier protein such as 0.1% BSA is strongly recommended to stabilize the protein in dilute solutions.
  • Freeze-Thaw Cycles: Avoid more than one freeze-thaw cycle per aliquot. Repeated freeze-thaw cycles cause protein aggregation and significant loss of biological activity.
  • Avoid: Storing protein at room temperature for extended periods, exposing to direct light, or contaminating stock solutions with biological material.

Specific stability data including shelf-life under defined conditions are provided on the lot-specific CoA. Contact Aladdin Scientific technical support for guidance if storage conditions deviate from recommendations.

Research Applications

Recombinant Human Angiopoietin-2 Protein is a versatile research reagent suitable for a broad range of in vitro and in vivo applications in vascular biology, oncology, and inflammation research.

  • Cell-Based Functional Assays: Ang-2 is used to modulate Tie2 receptor signaling in human umbilical vein endothelial cells (HUVECs) and other endothelial cell lines. Assays include Tie2 phosphorylation analysis, endothelial cell migration (scratch/wound-healing assay), tube formation assay, and cell survival/apoptosis studies.
  • Receptor Binding Studies: Ang-2 is used to characterize Tie2 receptor binding affinity and to compete with Ang-1 in ligand-binding experiments.
  • Angiogenesis Models: In ex vivo aortic ring assays and in vivo Matrigel plug or corneal micropocket assays, Ang-2 can be used to modulate angiogenic responses in the presence or absence of co-stimulatory factors such as VEGF.
  • Cytokine Crosstalk Studies: Ang-2 is used to investigate interactions with VEGF, TNF-α, and other inflammatory mediators in the context of vascular inflammation and tumor microenvironment biology.
  • Drug Discovery and Target Validation: As a clinically relevant angiogenic target, Ang-2 recombinant protein is used in screening assays to evaluate the activity of Tie2 pathway inhibitors and anti-angiogenic compounds.

Optimal concentrations and assay conditions should be determined empirically for each specific experimental system.

Frequently asked questions

What is the recommended reconstitution buffer for Recombinant Human Angiopoietin-2 Protein?

The lyophilized protein is typically reconstituted in sterile ultrapure water or phosphate-buffered saline (pH 7.4) supplemented with 0.1–0.2% BSA as a carrier protein. Always refer to the specific product datasheet for SKU rp365025 for the exact recommended buffer and volume, as formulation details may vary by lot.

How should I store reconstituted Angiopoietin-2 to maintain activity?

After reconstitution, prepare single-use aliquots and store them at -80°C for long-term preservation. For use within one week, aliquots can be stored at 2–8°C. Avoid repeated freeze-thaw cycles, as they cause protein aggregation and loss of biological activity. The addition of 0.1% BSA to working solutions is recommended to enhance stability.

What functional assays can I use to confirm the bioactivity of Ang-2?

Bioactivity of Recombinant Human Angiopoietin-2 can be confirmed using several assays: inhibition of Ang-1-induced Tie2 receptor phosphorylation in endothelial cells (e.g., HUVECs), endothelial cell migration assays, or tube formation assays on Matrigel. Dose-response analysis across a range of concentrations (typically 100 ng/mL to 1 µg/mL) is recommended to establish the effective concentration for your specific cell system.

Is Recombinant Human Angiopoietin-2 suitable for in vivo studies?

Recombinant Human Angiopoietin-2 Protein can be used in ex vivo and certain in vivo model systems, such as Matrigel plug assays or corneal micropocket assays, to study angiogenic responses. For in vivo use, ensure the endotoxin level of the specific lot is within acceptable limits (typically <1.0 EU/µg) and confirm suitability with your institutional animal care guidelines. Consult the lot-specific CoA and contact Aladdin Scientific technical support for further guidance.

References

  1. Yancopoulos GD, et al. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407(6801):242-248. doi:10.1038/35025215
  2. Augustin HG, et al. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nature Reviews Molecular Cell Biology. 2009;10(3):165-177. doi:10.1038/nrm2639
  3. Maisonpierre PC, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277(5322):55-60. doi:10.1126/science.277.5322.55

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 实验方案(Protocols)

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Recombinant Human Angiopoietin-2 Protein: Research Guide》. 阿拉丁知识库,更新于 2026年10月26日。 https://www.aladdin-e.com/zh_cn/faqs/recombinant-human-angiopoietin-2-protein-research-guide-en.html